DocCheck AG

DocCheck AG

10.10
EUR
0.00
(0.00%)
61.90MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3.56
3.99
5.37
5.2
5.63
5.68
6.48
12.55
17.07
12.1
10.54
10.6
10.9
- -
Basic EPS, GAAP
0.22
0.34
0.58
0.53
0.48
0.46
0.63
1.83
2.27
1.25
0.45
1.04
1.05
- -
Free Cash Flow per Basic Share
0.23
0.42
0.35
0.4
0.37
0.26
0.15
1.62
1.37
-0.1
1.11
1.28
0.44
- -
Dividend per Share
0.2
0.2
0.35
0.4
0.4
0.4
0.4
0.1
1
1
0.75
0.5
0.75
- -
Book Value per Share
3.51
3.65
3.88
4.01
4.11
4.17
4.41
6.15
7.41
7.66
7.36
7.9
8.2
8.2
Tangible Book Value per Share
3.44
3.6
3.83
3.97
4.06
4.07
4.31
6.05
7.26
7.58
7.25
7.78
8.05
8.05
Basic Weighted Avg Shares
5
5
5
5
5
5
5
5
5
5
5
5
5
5
Sales/Revenue/Turnover
18
20
27
26
28
28
32
63
86
61
53
54
55
- -
Operating Margin (%)
7.91
12.65
14.9
15.47
12.35
11.62
13.29
21.17
19.3
14.66
5.94
11.84
15.86
- -
Depreciation Expense
1
1
1
1
1
1
2
2
2
3
5
2
3
- -
Net Income, GAAP
1
2
3
3
2
2
3
9
11
6
2
5
5
- -
Effective Tax Rate (%)
33.35
35.4
33.2
33.93
33.05
34.26
32.83
30.71
31.6
32.73
51.42
30.09
36.07
- -
Profit Margin (%)
6.12
8.52
10.75
10.28
8.59
8.03
9.71
14.58
13.27
10.33
4.25
9.82
9.64
- -
Working Capital
8
10
9
10
10
10
11
20
24
21
21
24
23
23
LT Debt
- -
- -
- -
- -
- -
- -
2
1
6
6
5
4
3
3
Total Equity
18
19
20
20
21
21
22
31
38
39
38
40
42
42
Return on Invested Capital (%)
5.19
8.04
13.27
12.34
10.68
11.08
12.82
30.81
27.14
14.16
3.45
9.39
10.59
- -
Return on Capital (%)
6.18
9.76
15.66
13.49
12.28
12.48
14.78
31.12
28.53
15.53
5.48
12.17
12.32
- -
Return on Common Equity (%)
6.23
9.49
15.35
13.53
11.9
11.01
14.66
34.77
33.43
16.58
5.99
13.65
13.06
- -

Capital Structure

EUR

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
1
- -
1
LT Borrowings
- -
- -
- -
LT Finance Leases
4
- -
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
5
Market Capitalization
41
60
62

Working Capital

EUR

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
38
33
34
Cash, Cash Equivalents & STI
21
20
19
Accounts Receivable, Net
8
6
8
Inventories
3
4
3
Total Current Liabilities
14
11
11
Payables & Accruals
- -
- -
- -
ST Debt
1
- -
1
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.46%
6.14%
3.81%
Free Cash Flow
-48.14%
-281.33%
-65.61%
Net Income, GAAP
25.72%
9.75%
0.96%
Sales/Revenue/Turnover
11.35%
-0.34%
2.84%
Total Cash Common Dividend
- -
- -
50%

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
53
2024
- -
- -
54
2025
- -
- -
55

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.45
2024
- -
- -
1.04
2025
- -
- -
1.05

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.75
2024
- -
- -
0.5
2025
- -
- -
0.75

Company Description

CEO
Frank Nicolas Antwerpes
Full Time Employees
414
Sector
Distribution services
Industry
Medical distributors
Address
Vogelsanger Str. 66 Cologne NW Germany 50823
IPO Date
Nov 4, 2011
Business
DocCheck AG DocCheck AG operates Europe's largest online community for healthcare professionals, with over one million members, providing verified identification services that grant access to restricted medical and pharmaceutical information; it offers marketing and e-commerce solutions tailored to the healthcare sector, including the DocCheck agency for creative digital marketing, data-driven media planning, eMarketing, marketing automation, eDetailing, site building, apps, non-treatment-care software tools, social media campaigns via DocCheck health share, and SEO/SEM strategies as a certified Google partner; additionally, the DocCheck Shop serves as a leading European online retailer for over 15,000 medical and office supplies, including its own product line of around 200 items, supported by an ultra-modern warehouse and robotics in Hürth, Germany. The company, founded in 1990 and headquartered at Vogelsanger Str. 66 in Cologne, Germany, primarily targets physicians, medical assistants, pharmacists, and other healthcare professionals (HCPs) across Europe through its integrated platform combining professional networking, information exchange, online services, customer relationship management, market research, and logistics. Its subsidiaries, such as DocCheck Community GmbH, DocCheck Shop GmbH, DocCheck agency AG, DocCheck planning, and DocCheck health share, enable diversified operations in the digital healthcare market. In recent developments, DocCheck AG rebranded its communications agency from antwerpes to DocCheck Agency in July 2024; it reported preliminary financial results for the first half of 2025 in August 2025 and for the first quarter in May 2025; management changes included a shift in the executive board of DocCheck Shop GmbH on July 1, 2025, and alterations in the board of DocCheck agency AG involving Thilo Kolzer in February 2025.